RPRX
Royalty Pharma plc
48.57
2 x 44.46
2 x 52.29
bid
ask
+
0.08
0.16%
2 @ 04:00 PM
48.57 +0.00 (0.00%)
Ytd 25.70%
1y 55.27%
48.23
day range
49.04
30.85
52 week range
48.57
Open 48.25 Prev Close 48.49 Low 48.23 High 49.04 Mkt Cap 28.09B
Vol 2.72M Avg Vol 3.70M EPS 1.78 P/E 27.29 Forward P/E 8.92
Beta 0.42 Short Ratio 3.59 Inst. Own 87.57% Dividend 0.94 Div Yield 1.94
Ex Div Date 02-20 Earning 05-07 50-d Avg 44.98 200-d Avg 39.23 1yr Est 51.56
Earning
Date For Estimate Reported Surprise surprise %
2026-05-14 2026-03 1.18 N/A N/A N/A
2026-02-11 2025-12 1.33 1.46 0.13 9.77%
2025-11-05 2025-09 1.11 1.17 0.06 5.41%
2025-11-05 2025-09 1.11 N/A N/A N/A
2025-08-06 2025-06 1.1 1.14 0.04 3.64%
2025-08-06 2025-06 1.1 N/A N/A N/A
Upgrade / Downgrade
Date Firm Action From To
2026-01-27 Citigroup Upgrade Buy Buy
2025-12-11 TD Cowen Upgrade Buy Buy
2025-10-10 Morgan Stanley Upgrade Overweight Overweight
2025-09-30 Goldman Sachs Upgrade Buy
2025-07-22 Citigroup Upgrade Buy Buy
2025-07-10 Morgan Stanley Upgrade Overweight Overweight
Profile
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Insider Holder
Date Name Relation Quantity Description
2026-03-30 BASSLER BONNIE L Director 73.95K Stock Award(Grant)
2026-03-31 COYNE TERRANCE P Chief Financial Officer 0.00 Sale
2025-05-12 DESOUZA ERROL B Director 81.35K Stock Award(Grant)
2025-05-12 ENGELBERT CATHERINE M. Director 51.13K Stock Award(Grant)
2025-06-29 FERNANDEZ HENRY A Director 123.52K Stock Award(Grant)
2026-02-10 HITE CHRISTOPHER D. Officer 0.00 Stock Award(Grant)
Institution Ownership
Report Date Organization Position Value Percentage
2025-12-30 Morgan Stanley 55.27M 2.68B 12.90%
2025-12-30 Capital International Investors 31.10M 1.51B 7.26%
2025-12-30 FMR, LLC 26.27M 1.28B 6.13%
2025-12-30 Blackrock Inc. 26.19M 1.27B 6.11%
2025-12-30 BAILLIE GIFFORD & CO 17.01M 826.12M 3.97%
2025-12-30 Swedbank AB 11.94M 580.03M 2.79%
Fund Ownership
Report Date Organization Position Value Percentage
2025-12-30 NEW PERSPECTIVE FUND 10.09M 490.07M 2.36%
2025-12-30 AMERICAN BALANCED FUND 8.02M 389.51M 1.87%
2025-12-30 MORGAN STANLEY INSTITUTIONAL FUND INC-GROWTH PORTFOLIO 5.50M 267.35M 1.28%
2025-12-30 GROWTH FUND OF AMERICA 4.39M 213.01M 1.02%
2026-01-30 Capital Income Builder 4.22M 204.96M 0.98%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund 4.05M 196.65M 0.95%
Dividend
Dividend Date
0.235 2026-02-20
0.22 2025-11-14
0.22 2025-08-15
0.22 2025-05-16
0.22 2025-02-21
0.22 2025-02-20
Split
Split Date
0.25 : 1 2010-10-15